Absence of mucosal-associated invariant T cells in a person with a homozygous point mutation in


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
24 07 2020
Historique:
received: 22 05 2020
accepted: 11 06 2020
entrez: 26 7 2020
pubmed: 28 7 2020
medline: 11 1 2022
Statut: ppublish

Résumé

The role unconventional T cells play in protective immunity in humans is unclear. Mucosal-associated invariant T (MAIT) cells are an unconventional T cell subset restricted to the antigen-presenting molecule MR1. Here, we report the discovery of a patient homozygous for a rare Arg31His (R9H in the mature protein) mutation in MR1 who has a history of difficult-to-treat viral and bacterial infections. MR1

Identifiants

pubmed: 32709702
pii: 5/49/eabc9492
doi: 10.1126/sciimmunol.abc9492
pmc: PMC8581949
mid: NIHMS1641291
pii:
doi:

Substances chimiques

Histocompatibility Antigens Class I 0
MR1 protein, human 0
Minor Histocompatibility Antigens 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Intramural NIH HHS
ID : Z01 AI000615
Pays : United States

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

Nat Immunol. 2016 May;17(5):531-7
pubmed: 27043408
J Immunol. 2015 Mar 15;194(6):2696-705
pubmed: 25653426
SAGE Open Med Case Rep. 2019 Jun 19;7:2050313X19857416
pubmed: 31258907
Scand J Immunol. 2014 Dec;80(6):462-3
pubmed: 25196940
Sci Rep. 2016 Feb 03;6:20358
pubmed: 26837580
J Clin Immunol. 2019 Aug;39(6):532-556
pubmed: 31313072
Eur J Immunol. 2014 Oct;44(10):3119-28
pubmed: 25043505
J Exp Med. 2015 Jun 1;212(6):855-64
pubmed: 25941256
Cell. 2013 Jan 17;152(1-2):276-89
pubmed: 23273991
Nat Immunol. 2020 Apr;21(4):400-411
pubmed: 32123373
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Nat Commun. 2018 Jan 17;9(1):253
pubmed: 29343684
Nat Commun. 2017 Mar 08;8:14599
pubmed: 28272391
Blood. 2011 Jan 27;117(4):1250-9
pubmed: 21084709
J Allergy Clin Immunol. 2012 Nov;130(5):1030-48
pubmed: 23036745
Clin Immunol. 2006 Sep;120(3):310-8
pubmed: 16782407
J Immunol. 2019 Sep 15;203(6):1468-1479
pubmed: 31413106
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
J Exp Med. 2012 Apr 9;209(4):761-74
pubmed: 22412157
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
Front Genet. 2017 Sep 22;8:130
pubmed: 29018476
J Biol Chem. 2005 Jun 3;280(22):21183-93
pubmed: 15802267
J Exp Med. 2013 Oct 21;210(11):2305-20
pubmed: 24101382
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Dermatol Ther (Heidelb). 2017 Dec;7(4):549-554
pubmed: 28836173
Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1518-23
pubmed: 20080641
J Clin Microbiol. 2006 Nov;44(11):4157-62
pubmed: 17005760
Nat Commun. 2018 Nov 9;9(1):4706
pubmed: 30413689
Mucosal Immunol. 2017 Jan;10(1):58-68
pubmed: 27143301
Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8342-8347
pubmed: 28716935
Science. 2019 Oct 25;366(6464):494-499
pubmed: 31467190
Eur J Clin Chem Clin Biochem. 1996 Jun;34(6):517-20
pubmed: 8831057
Science. 2019 Dec 20;366(6472):1522-1527
pubmed: 31857486
Nat Commun. 2013;4:2142
pubmed: 23846752
Nat Commun. 2018 May 2;9(1):1760
pubmed: 29720665
mSphere. 2018 Dec 12;3(6):
pubmed: 30541782
Nat Immunol. 2016 Nov;17(11):1300-1311
pubmed: 27668799
J Exp Med. 2017 Jul 3;214(7):1949-1972
pubmed: 28606988
PLoS One. 2015 Nov 23;10(11):e0143199
pubmed: 26600436
Mol Immunol. 2011 Feb;48(5):769-75
pubmed: 21190736
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):E3119-28
pubmed: 23898209
J Exp Med. 2014 Jul 28;211(8):1585-600
pubmed: 25049336
Sci Immunol. 2018 Dec 21;3(30):
pubmed: 30578351
Science. 2015 Aug 7;349(6248):606-613
pubmed: 26160376
Nature. 2012 Nov 29;491(7426):717-23
pubmed: 23051753
Nat Commun. 2016 Jun 23;7:11653
pubmed: 27337592
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Acta Crystallogr D Biol Crystallogr. 2007 Jan;63(Pt 1):32-41
pubmed: 17164524
Nature. 2014 May 15;509(7500):361-5
pubmed: 24695216
Nat Immunol. 2015 Nov;16(11):1114-23
pubmed: 26482978
Nat Commun. 2019 Feb 8;10(1):687
pubmed: 30737409
Vaccine. 2006 Mar 30;24 Suppl 1:S16-22
pubmed: 16219398

Auteurs

Lauren J Howson (LJ)

Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia. jamie.rossjohn@monash.edu lauren.howson@monash.edu.

Wael Awad (W)

Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria, Australia.

Anouk von Borstel (A)

Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.

Hui Jing Lim (HJ)

Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia.

Hamish E G McWilliam (HEG)

Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia.
Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.

Maria L Sandoval-Romero (ML)

Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.

Shamik Majumdar (S)

Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.

Abdul Rezzak Hamzeh (AR)

Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Acton, Australian Capital Territory, Australia.
Department of Immunology, Canberra Hospital, Canberra, Australian Capital Territory, Australia.

Thomas D Andrews (TD)

Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Acton, Australian Capital Territory, Australia.
Department of Immunology, Canberra Hospital, Canberra, Australian Capital Territory, Australia.

David H McDermott (DH)

Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.

Philip M Murphy (PM)

Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.

Jérôme Le Nours (J)

Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria, Australia.

Jeffrey Y W Mak (JYW)

Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
ARC Centre of Excellence in Advanced Molecular Imaging, University of Queensland, Brisbane, Queensland, Australia.

Ligong Liu (L)

Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
ARC Centre of Excellence in Advanced Molecular Imaging, University of Queensland, Brisbane, Queensland, Australia.

David P Fairlie (DP)

Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
ARC Centre of Excellence in Advanced Molecular Imaging, University of Queensland, Brisbane, Queensland, Australia.

James McCluskey (J)

Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia.

Jose A Villadangos (JA)

Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia.
Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.

Matthew C Cook (MC)

Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Acton, Australian Capital Territory, Australia.
Department of Immunology, Canberra Hospital, Canberra, Australian Capital Territory, Australia.

Stephen J Turner (SJ)

Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.

Martin S Davey (MS)

Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.

Samar Ojaimi (S)

Department of Infectious Diseases, Monash Health, Clayton, Victoria, Australia.
Centre for Inflammatory Diseases, Monash University, Clayton, Victoria, Australia.
Department of Allergy and Immunology, Monash Health, Clayton, Victoria, Australia.

Jamie Rossjohn (J)

Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia. jamie.rossjohn@monash.edu lauren.howson@monash.edu.
Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria, Australia.
Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH